Apr 8 |
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
|
Apr 8 |
BLCO vs. AVTR: Which Stock Is the Better Value Option?
|
Apr 5 |
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
|
Apr 3 |
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/
|
Apr 3 |
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
|
Apr 3 |
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
|
Apr 2 |
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
|
Apr 1 |
Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)
|
Mar 28 |
The Enduring Losses Incurred by Carl Icahn’s 10 Activist Targets over the Long Term
|
Mar 28 |
Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
|